Story at-a-glance

• The U.S. Food and Drug Administration (FDA) is requiring additional warning labels for the cholesterol-lowering drug class known as statins, warning that the drugs may increase your risk of liver damage, memory loss and confusion, type 2 diabetes and muscle weakness

• The FDA has removed Continue reading →